nodes	percent_of_prediction	percent_of_DWPC	metapath
Probenecid—ABCC6—Dactinomycin—sarcoma	0.174	0.198	CbGbCtD
Probenecid—ABCC6—Etoposide—sarcoma	0.0982	0.112	CbGbCtD
Probenecid—ABCC6—Doxorubicin—sarcoma	0.067	0.0761	CbGbCtD
Probenecid—ABCC3—Vincristine—sarcoma	0.0515	0.0585	CbGbCtD
Probenecid—ABCC1—Dactinomycin—sarcoma	0.0513	0.0583	CbGbCtD
Probenecid—SLC22A5—Dactinomycin—sarcoma	0.0488	0.0555	CbGbCtD
Probenecid—ABCC3—Etoposide—sarcoma	0.0472	0.0536	CbGbCtD
Probenecid—ABCC1—Mitoxantrone—sarcoma	0.0459	0.0522	CbGbCtD
Probenecid—ABCC1—Epirubicin—sarcoma	0.0372	0.0423	CbGbCtD
Probenecid—ABCC3—Doxorubicin—sarcoma	0.0322	0.0366	CbGbCtD
Probenecid—ABCC1—Vincristine—sarcoma	0.0316	0.0359	CbGbCtD
Probenecid—ABCC1—Etoposide—sarcoma	0.029	0.0329	CbGbCtD
Probenecid—ABCC2—Vincristine—sarcoma	0.0234	0.0266	CbGbCtD
Probenecid—ABCC2—Etoposide—sarcoma	0.0214	0.0244	CbGbCtD
Probenecid—ABCC1—Doxorubicin—sarcoma	0.0198	0.0225	CbGbCtD
Probenecid—CYP3A4—Thiotepa—sarcoma	0.0154	0.0176	CbGbCtD
Probenecid—ABCC2—Doxorubicin—sarcoma	0.0146	0.0166	CbGbCtD
Probenecid—ABCB1—Dactinomycin—sarcoma	0.0124	0.0141	CbGbCtD
Probenecid—ABCB1—Mitoxantrone—sarcoma	0.0111	0.0126	CbGbCtD
Probenecid—CYP2C8—Etoposide—sarcoma	0.0103	0.0117	CbGbCtD
Probenecid—ABCC6—dermis—sarcoma	0.00778	0.0882	CbGeAlD
Probenecid—ABCB1—Vincristine—sarcoma	0.00763	0.00867	CbGbCtD
Probenecid—SLC2A9—cartilage tissue—sarcoma	0.00743	0.0843	CbGeAlD
Probenecid—ABCB1—Etoposide—sarcoma	0.00699	0.00794	CbGbCtD
Probenecid—CYP3A4—Mitoxantrone—sarcoma	0.00664	0.00755	CbGbCtD
Probenecid—ABCB1—Doxorubicin—sarcoma	0.00477	0.00542	CbGbCtD
Probenecid—CYP3A4—Vincristine—sarcoma	0.00457	0.00519	CbGbCtD
Probenecid—CYP3A4—Etoposide—sarcoma	0.00419	0.00476	CbGbCtD
Probenecid—ABCC6—Podofilox—Etoposide—sarcoma	0.00355	1	CbGdCrCtD
Probenecid—ABCC11—mammary gland—sarcoma	0.00333	0.0378	CbGeAlD
Probenecid—SLC22A10—liver—sarcoma	0.00296	0.0336	CbGeAlD
Probenecid—CYP3A4—Doxorubicin—sarcoma	0.00286	0.00325	CbGbCtD
Probenecid—PANX1—myometrium—sarcoma	0.00247	0.028	CbGeAlD
Probenecid—ABCC11—embryo—sarcoma	0.00227	0.0258	CbGeAlD
Probenecid—PANX1—seminal vesicle—sarcoma	0.00223	0.0253	CbGeAlD
Probenecid—PANX1—hematopoietic system—sarcoma	0.00212	0.024	CbGeAlD
Probenecid—PANX1—connective tissue—sarcoma	0.00204	0.0231	CbGeAlD
Probenecid—SLC2A9—seminal vesicle—sarcoma	0.00202	0.0229	CbGeAlD
Probenecid—SLC2A9—connective tissue—sarcoma	0.00185	0.021	CbGeAlD
Probenecid—PANX1—uterus—sarcoma	0.0016	0.0181	CbGeAlD
Probenecid—PANX1—tendon—sarcoma	0.0014	0.0159	CbGeAlD
Probenecid—SLC16A7—myometrium—sarcoma	0.00132	0.015	CbGeAlD
Probenecid—ABCC5—mammary gland—sarcoma	0.0013	0.0148	CbGeAlD
Probenecid—ABCC6—hematopoietic system—sarcoma	0.00117	0.0132	CbGeAlD
Probenecid—PANX1—testis—sarcoma	0.00116	0.0132	CbGeAlD
Probenecid—ABCC6—connective tissue—sarcoma	0.00112	0.0127	CbGeAlD
Probenecid—SLC10A1—seminal vesicle—sarcoma	0.00111	0.0126	CbGeAlD
Probenecid—ABCC11—testis—sarcoma	0.00111	0.0126	CbGeAlD
Probenecid—PANX1—liver—sarcoma	0.0011	0.0124	CbGeAlD
Probenecid—SLC2A9—testis—sarcoma	0.00105	0.0119	CbGeAlD
Probenecid—ABCC11—liver—sarcoma	0.00105	0.0119	CbGeAlD
Probenecid—SLC2A9—liver—sarcoma	0.000995	0.0113	CbGeAlD
Probenecid—ALB—mammary gland—sarcoma	0.000932	0.0106	CbGeAlD
Probenecid—SLC16A7—cardiac atrium—sarcoma	0.00086	0.00975	CbGeAlD
Probenecid—SLC16A7—uterus—sarcoma	0.000856	0.0097	CbGeAlD
Probenecid—Aplastic anaemia—Dactinomycin—sarcoma	0.000849	0.0301	CcSEcCtD
Probenecid—PANX1—lymph node—sarcoma	0.000841	0.00954	CbGeAlD
Probenecid—SLC2A9—lymph node—sarcoma	0.000763	0.00865	CbGeAlD
Probenecid—SLC16A7—tendon—sarcoma	0.00075	0.0085	CbGeAlD
Probenecid—SLC16A1—hematopoietic system—sarcoma	0.000721	0.00818	CbGeAlD
Probenecid—SLC22A5—mammary gland—sarcoma	0.000676	0.00767	CbGeAlD
Probenecid—ABCC3—hematopoietic system—sarcoma	0.000666	0.00755	CbGeAlD
Probenecid—CYP2C8—mammary gland—sarcoma	0.000655	0.00742	CbGeAlD
Probenecid—SLC16A7—testis—sarcoma	0.000621	0.00704	CbGeAlD
Probenecid—ABCC6—liver—sarcoma	0.000604	0.00685	CbGeAlD
Probenecid—ABCC5—cardiac atrium—sarcoma	0.000602	0.00683	CbGeAlD
Probenecid—Toxic epidermal necrolysis—Dactinomycin—sarcoma	0.000591	0.021	CcSEcCtD
Probenecid—SLC16A7—liver—sarcoma	0.000587	0.00666	CbGeAlD
Probenecid—CYP2C9—mammary gland—sarcoma	0.000582	0.00659	CbGeAlD
Probenecid—SLC10A1—testis—sarcoma	0.00058	0.00658	CbGeAlD
Probenecid—SLCO1A2—hematopoietic system—sarcoma	0.000571	0.00647	CbGeAlD
Probenecid—ABCC4—hematopoietic system—sarcoma	0.000549	0.00623	CbGeAlD
Probenecid—SLC10A1—liver—sarcoma	0.000548	0.00622	CbGeAlD
Probenecid—SLC16A1—cardiac atrium—sarcoma	0.000548	0.00621	CbGeAlD
Probenecid—ABCC1—myometrium—sarcoma	0.000546	0.00619	CbGeAlD
Probenecid—SLCO1C1—testis—sarcoma	0.000545	0.00618	CbGeAlD
Probenecid—SLC22A8—hematopoietic system—sarcoma	0.000545	0.00618	CbGeAlD
Probenecid—SLC16A1—uterus—sarcoma	0.000545	0.00618	CbGeAlD
Probenecid—ABCC5—tendon—sarcoma	0.000525	0.00595	CbGeAlD
Probenecid—SLC22A7—testis—sarcoma	0.000517	0.00586	CbGeAlD
Probenecid—ABCC5—bone marrow—sarcoma	0.000508	0.00576	CbGeAlD
Probenecid—Stevens-Johnson syndrome—Dactinomycin—sarcoma	0.000501	0.0178	CcSEcCtD
Probenecid—SLC22A11—liver—sarcoma	0.000501	0.00568	CbGeAlD
Probenecid—ABCC1—seminal vesicle—sarcoma	0.000493	0.00559	CbGeAlD
Probenecid—SLC22A7—liver—sarcoma	0.000489	0.00554	CbGeAlD
Probenecid—Haematuria—Thiotepa—sarcoma	0.000486	0.0172	CcSEcCtD
Probenecid—SLC22A5—myometrium—sarcoma	0.00048	0.00544	CbGeAlD
Probenecid—SLC16A1—tendon—sarcoma	0.000477	0.00541	CbGeAlD
Probenecid—CYP2C19—hematopoietic system—sarcoma	0.000457	0.00518	CbGeAlD
Probenecid—SLC16A7—lymph node—sarcoma	0.00045	0.0051	CbGeAlD
Probenecid—ABCC5—testis—sarcoma	0.000434	0.00493	CbGeAlD
Probenecid—SLC22A5—seminal vesicle—sarcoma	0.000434	0.00492	CbGeAlD
Probenecid—Erythema multiforme—Dactinomycin—sarcoma	0.000429	0.0152	CcSEcCtD
Probenecid—Toxic epidermal necrolysis—Etoposide—sarcoma	0.000428	0.0152	CcSEcCtD
Probenecid—Flushing—Dactinomycin—sarcoma	0.000421	0.015	CcSEcCtD
Probenecid—Haematuria—Mitoxantrone—sarcoma	0.00042	0.0149	CcSEcCtD
Probenecid—ABCC4—uterus—sarcoma	0.000415	0.00471	CbGeAlD
Probenecid—ABCC5—liver—sarcoma	0.000411	0.00466	CbGeAlD
Probenecid—Alopecia—Thiotepa—sarcoma	0.000404	0.0143	CcSEcCtD
Probenecid—Alopecia—Dactinomycin—sarcoma	0.000401	0.0142	CcSEcCtD
Probenecid—CYP2C8—hematopoietic system—sarcoma	0.000399	0.00452	CbGeAlD
Probenecid—SLC16A1—testis—sarcoma	0.000395	0.00448	CbGeAlD
Probenecid—SLCO1C1—lymph node—sarcoma	0.000395	0.00448	CbGeAlD
Probenecid—SLC16A1—liver—sarcoma	0.000374	0.00424	CbGeAlD
Probenecid—Anaemia—Thiotepa—sarcoma	0.000368	0.0131	CcSEcCtD
Probenecid—Anaemia—Dactinomycin—sarcoma	0.000365	0.013	CcSEcCtD
Probenecid—ABCC3—testis—sarcoma	0.000365	0.00414	CbGeAlD
Probenecid—ABCC4—tendon—sarcoma	0.000364	0.00412	CbGeAlD
Probenecid—Stevens-Johnson syndrome—Etoposide—sarcoma	0.000363	0.0129	CcSEcCtD
Probenecid—Alopecia—Vincristine—sarcoma	0.000358	0.0127	CcSEcCtD
Probenecid—SLC22A5—skin of body—sarcoma	0.000358	0.00406	CbGeAlD
Probenecid—Leukopenia—Thiotepa—sarcoma	0.000356	0.0126	CcSEcCtD
Probenecid—ABCC1—cardiac atrium—sarcoma	0.000356	0.00403	CbGeAlD
Probenecid—CYP2C9—hematopoietic system—sarcoma	0.000354	0.00402	CbGeAlD
Probenecid—ABCC1—uterus—sarcoma	0.000354	0.00401	CbGeAlD
Probenecid—Leukopenia—Dactinomycin—sarcoma	0.000354	0.0126	CcSEcCtD
Probenecid—ABCC4—bone marrow—sarcoma	0.000352	0.00399	CbGeAlD
Probenecid—ABCC2—tendon—sarcoma	0.000352	0.00399	CbGeAlD
Probenecid—Alopecia—Mitoxantrone—sarcoma	0.000349	0.0124	CcSEcCtD
Probenecid—ABCC3—liver—sarcoma	0.000345	0.00391	CbGeAlD
Probenecid—Aplastic anaemia—Epirubicin—sarcoma	0.000344	0.0122	CcSEcCtD
Probenecid—Anaemia—Vincristine—sarcoma	0.000326	0.0116	CcSEcCtD
Probenecid—Aplastic anaemia—Doxorubicin—sarcoma	0.000319	0.0113	CcSEcCtD
Probenecid—Anaemia—Mitoxantrone—sarcoma	0.000318	0.0113	CcSEcCtD
Probenecid—Leukopenia—Vincristine—sarcoma	0.000316	0.0112	CcSEcCtD
Probenecid—ABCC5—lymph node—sarcoma	0.000315	0.00357	CbGeAlD
Probenecid—SLCO1A2—testis—sarcoma	0.000313	0.00355	CbGeAlD
Probenecid—SLC22A5—cardiac atrium—sarcoma	0.000313	0.00355	CbGeAlD
Probenecid—ALB—testis—sarcoma	0.000311	0.00353	CbGeAlD
Probenecid—Erythema multiforme—Etoposide—sarcoma	0.000311	0.011	CcSEcCtD
Probenecid—ABCC1—tendon—sarcoma	0.00031	0.00352	CbGeAlD
Probenecid—Anorexia—Thiotepa—sarcoma	0.00031	0.011	CcSEcCtD
Probenecid—Leukopenia—Mitoxantrone—sarcoma	0.000308	0.0109	CcSEcCtD
Probenecid—Anorexia—Dactinomycin—sarcoma	0.000307	0.0109	CcSEcCtD
Probenecid—SLC22A1—liver—sarcoma	0.000307	0.00348	CbGeAlD
Probenecid—Flushing—Etoposide—sarcoma	0.000305	0.0108	CcSEcCtD
Probenecid—ABCC4—testis—sarcoma	0.000301	0.00341	CbGeAlD
Probenecid—SLCO1A2—liver—sarcoma	0.000296	0.00335	CbGeAlD
Probenecid—ALB—liver—sarcoma	0.000294	0.00333	CbGeAlD
Probenecid—ABCC2—testis—sarcoma	0.000291	0.00331	CbGeAlD
Probenecid—Alopecia—Etoposide—sarcoma	0.00029	0.0103	CcSEcCtD
Probenecid—Anaphylactic shock—Vincristine—sarcoma	0.000288	0.0102	CcSEcCtD
Probenecid—SLC16A1—lymph node—sarcoma	0.000286	0.00325	CbGeAlD
Probenecid—ABCC4—liver—sarcoma	0.000285	0.00323	CbGeAlD
Probenecid—Decreased appetite—Thiotepa—sarcoma	0.000283	0.01	CcSEcCtD
Probenecid—Anaphylactic shock—Mitoxantrone—sarcoma	0.000281	0.00996	CcSEcCtD
Probenecid—Decreased appetite—Dactinomycin—sarcoma	0.00028	0.00995	CcSEcCtD
Probenecid—Pain—Thiotepa—sarcoma	0.000278	0.00986	CcSEcCtD
Probenecid—Pain—Dactinomycin—sarcoma	0.000276	0.00979	CcSEcCtD
Probenecid—ABCC2—liver—sarcoma	0.000276	0.00312	CbGeAlD
Probenecid—Anorexia—Vincristine—sarcoma	0.000275	0.00975	CcSEcCtD
Probenecid—SLC22A5—tendon—sarcoma	0.000273	0.00309	CbGeAlD
Probenecid—CYP3A4—hematopoietic system—sarcoma	0.00027	0.00306	CbGeAlD
Probenecid—Anorexia—Mitoxantrone—sarcoma	0.000268	0.00949	CcSEcCtD
Probenecid—ABCC3—lymph node—sarcoma	0.000264	0.003	CbGeAlD
Probenecid—Anaemia—Etoposide—sarcoma	0.000264	0.00938	CcSEcCtD
Probenecid—Urticaria—Thiotepa—sarcoma	0.000258	0.00916	CcSEcCtD
Probenecid—Body temperature increased—Thiotepa—sarcoma	0.000257	0.00912	CcSEcCtD
Probenecid—ABCC1—testis—sarcoma	0.000257	0.00291	CbGeAlD
Probenecid—Leukopenia—Etoposide—sarcoma	0.000256	0.00909	CcSEcCtD
Probenecid—Body temperature increased—Dactinomycin—sarcoma	0.000255	0.00905	CcSEcCtD
Probenecid—Decreased appetite—Vincristine—sarcoma	0.000251	0.00889	CcSEcCtD
Probenecid—Pain—Vincristine—sarcoma	0.000246	0.00875	CcSEcCtD
Probenecid—Decreased appetite—Mitoxantrone—sarcoma	0.000244	0.00866	CcSEcCtD
Probenecid—ABCC1—liver—sarcoma	0.000243	0.00275	CbGeAlD
Probenecid—Pain—Mitoxantrone—sarcoma	0.00024	0.00852	CcSEcCtD
Probenecid—Toxic epidermal necrolysis—Epirubicin—sarcoma	0.00024	0.00851	CcSEcCtD
Probenecid—Hypersensitivity—Thiotepa—sarcoma	0.000239	0.0085	CcSEcCtD
Probenecid—Hypersensitivity—Dactinomycin—sarcoma	0.000238	0.00843	CcSEcCtD
Probenecid—CYP2C19—liver—sarcoma	0.000237	0.00269	CbGeAlD
Probenecid—Anaphylactic shock—Etoposide—sarcoma	0.000233	0.00828	CcSEcCtD
Probenecid—Pruritus—Thiotepa—sarcoma	0.00023	0.00816	CcSEcCtD
Probenecid—Body temperature increased—Vincristine—sarcoma	0.000228	0.00808	CcSEcCtD
Probenecid—SLC22A5—testis—sarcoma	0.000226	0.00256	CbGeAlD
Probenecid—ALB—lymph node—sarcoma	0.000225	0.00256	CbGeAlD
Probenecid—Urticaria—Mitoxantrone—sarcoma	0.000223	0.00791	CcSEcCtD
Probenecid—ABCB1—myometrium—sarcoma	0.000223	0.00253	CbGeAlD
Probenecid—Anorexia—Etoposide—sarcoma	0.000223	0.0079	CcSEcCtD
Probenecid—Body temperature increased—Mitoxantrone—sarcoma	0.000222	0.00787	CcSEcCtD
Probenecid—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.000222	0.00787	CcSEcCtD
Probenecid—CYP2C8—testis—sarcoma	0.000219	0.00248	CbGeAlD
Probenecid—ABCC4—lymph node—sarcoma	0.000218	0.00247	CbGeAlD
Probenecid—Dizziness—Thiotepa—sarcoma	0.000215	0.00763	CcSEcCtD
Probenecid—ABCB1—embryo—sarcoma	0.000214	0.00243	CbGeAlD
Probenecid—SLC22A5—liver—sarcoma	0.000213	0.00242	CbGeAlD
Probenecid—Pollakiuria—Epirubicin—sarcoma	0.000213	0.00754	CcSEcCtD
Probenecid—Hypersensitivity—Vincristine—sarcoma	0.000212	0.00753	CcSEcCtD
Probenecid—ABCC2—lymph node—sarcoma	0.000211	0.0024	CbGeAlD
Probenecid—Hypersensitivity—Mitoxantrone—sarcoma	0.000207	0.00734	CcSEcCtD
Probenecid—CYP2C8—liver—sarcoma	0.000207	0.00234	CbGeAlD
Probenecid—Vomiting—Thiotepa—sarcoma	0.000207	0.00733	CcSEcCtD
Probenecid—Vomiting—Dactinomycin—sarcoma	0.000205	0.00728	CcSEcCtD
Probenecid—Dermatitis—Thiotepa—sarcoma	0.000205	0.00726	CcSEcCtD
Probenecid—Headache—Thiotepa—sarcoma	0.000204	0.00722	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000203	0.00722	CcSEcCtD
Probenecid—Decreased appetite—Etoposide—sarcoma	0.000203	0.0072	CcSEcCtD
Probenecid—ABCB1—seminal vesicle—sarcoma	0.000201	0.00228	CbGeAlD
Probenecid—Pain—Etoposide—sarcoma	0.0002	0.00708	CcSEcCtD
Probenecid—Pollakiuria—Doxorubicin—sarcoma	0.000197	0.00698	CcSEcCtD
Probenecid—Haematuria—Epirubicin—sarcoma	0.000196	0.00694	CcSEcCtD
Probenecid—Nausea—Thiotepa—sarcoma	0.000193	0.00685	CcSEcCtD
Probenecid—Nausea—Dactinomycin—sarcoma	0.000192	0.0068	CcSEcCtD
Probenecid—ABCB1—hematopoietic system—sarcoma	0.000191	0.00217	CbGeAlD
Probenecid—Dizziness—Vincristine—sarcoma	0.000191	0.00676	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000188	0.00668	CcSEcCtD
Probenecid—ABCC1—lymph node—sarcoma	0.000186	0.00211	CbGeAlD
Probenecid—Urticaria—Etoposide—sarcoma	0.000185	0.00658	CcSEcCtD
Probenecid—Body temperature increased—Etoposide—sarcoma	0.000185	0.00655	CcSEcCtD
Probenecid—CYP2C9—liver—sarcoma	0.000184	0.00208	CbGeAlD
Probenecid—Vomiting—Vincristine—sarcoma	0.000183	0.0065	CcSEcCtD
Probenecid—Dermatitis—Vincristine—sarcoma	0.000182	0.00644	CcSEcCtD
Probenecid—Haematuria—Doxorubicin—sarcoma	0.000181	0.00642	CcSEcCtD
Probenecid—Headache—Vincristine—sarcoma	0.000181	0.00641	CcSEcCtD
Probenecid—Vomiting—Mitoxantrone—sarcoma	0.000178	0.00633	CcSEcCtD
Probenecid—Dermatitis—Mitoxantrone—sarcoma	0.000177	0.00627	CcSEcCtD
Probenecid—Headache—Mitoxantrone—sarcoma	0.000176	0.00624	CcSEcCtD
Probenecid—Erythema multiforme—Epirubicin—sarcoma	0.000174	0.00618	CcSEcCtD
Probenecid—Hypersensitivity—Etoposide—sarcoma	0.000172	0.0061	CcSEcCtD
Probenecid—Nausea—Vincristine—sarcoma	0.000171	0.00607	CcSEcCtD
Probenecid—Flushing—Epirubicin—sarcoma	0.000171	0.00607	CcSEcCtD
Probenecid—Nausea—Mitoxantrone—sarcoma	0.000167	0.00592	CcSEcCtD
Probenecid—Pruritus—Etoposide—sarcoma	0.000165	0.00586	CcSEcCtD
Probenecid—SLC22A5—lymph node—sarcoma	0.000164	0.00186	CbGeAlD
Probenecid—Alopecia—Epirubicin—sarcoma	0.000163	0.00578	CcSEcCtD
Probenecid—Erythema multiforme—Doxorubicin—sarcoma	0.000161	0.00572	CcSEcCtD
Probenecid—Flushing—Doxorubicin—sarcoma	0.000158	0.00561	CcSEcCtD
Probenecid—Dizziness—Etoposide—sarcoma	0.000154	0.00548	CcSEcCtD
Probenecid—Alopecia—Doxorubicin—sarcoma	0.000151	0.00534	CcSEcCtD
Probenecid—Vomiting—Etoposide—sarcoma	0.000148	0.00527	CcSEcCtD
Probenecid—Anaemia—Epirubicin—sarcoma	0.000148	0.00526	CcSEcCtD
Probenecid—Dermatitis—Etoposide—sarcoma	0.000147	0.00522	CcSEcCtD
Probenecid—Headache—Etoposide—sarcoma	0.000146	0.00519	CcSEcCtD
Probenecid—ABCB1—uterus—sarcoma	0.000144	0.00164	CbGeAlD
Probenecid—Leukopenia—Epirubicin—sarcoma	0.000144	0.00509	CcSEcCtD
Probenecid—CYP3A4—liver—sarcoma	0.00014	0.00159	CbGeAlD
Probenecid—Nausea—Etoposide—sarcoma	0.000139	0.00492	CcSEcCtD
Probenecid—Anaemia—Doxorubicin—sarcoma	0.000137	0.00487	CcSEcCtD
Probenecid—ABCB1—lymphoid tissue—sarcoma	0.000135	0.00153	CbGeAlD
Probenecid—Leukopenia—Doxorubicin—sarcoma	0.000133	0.00471	CcSEcCtD
Probenecid—Anaphylactic shock—Epirubicin—sarcoma	0.000131	0.00464	CcSEcCtD
Probenecid—Anorexia—Epirubicin—sarcoma	0.000125	0.00443	CcSEcCtD
Probenecid—ABCB1—bone marrow—sarcoma	0.000123	0.00139	CbGeAlD
Probenecid—Anaphylactic shock—Doxorubicin—sarcoma	0.000121	0.0043	CcSEcCtD
Probenecid—Anorexia—Doxorubicin—sarcoma	0.000115	0.0041	CcSEcCtD
Probenecid—Decreased appetite—Epirubicin—sarcoma	0.000114	0.00404	CcSEcCtD
Probenecid—Pain—Epirubicin—sarcoma	0.000112	0.00397	CcSEcCtD
Probenecid—Decreased appetite—Doxorubicin—sarcoma	0.000105	0.00374	CcSEcCtD
Probenecid—ABCB1—testis—sarcoma	0.000105	0.00119	CbGeAlD
Probenecid—Urticaria—Epirubicin—sarcoma	0.000104	0.00369	CcSEcCtD
Probenecid—Pain—Doxorubicin—sarcoma	0.000104	0.00367	CcSEcCtD
Probenecid—Body temperature increased—Epirubicin—sarcoma	0.000103	0.00367	CcSEcCtD
Probenecid—ABCB1—liver—sarcoma	9.91e-05	0.00112	CbGeAlD
Probenecid—Hypersensitivity—Epirubicin—sarcoma	9.64e-05	0.00342	CcSEcCtD
Probenecid—Urticaria—Doxorubicin—sarcoma	9.62e-05	0.00341	CcSEcCtD
Probenecid—Body temperature increased—Doxorubicin—sarcoma	9.57e-05	0.0034	CcSEcCtD
Probenecid—Pruritus—Epirubicin—sarcoma	9.26e-05	0.00329	CcSEcCtD
Probenecid—Hypersensitivity—Doxorubicin—sarcoma	8.92e-05	0.00317	CcSEcCtD
Probenecid—Dizziness—Epirubicin—sarcoma	8.65e-05	0.00307	CcSEcCtD
Probenecid—Pruritus—Doxorubicin—sarcoma	8.57e-05	0.00304	CcSEcCtD
Probenecid—Vomiting—Epirubicin—sarcoma	8.32e-05	0.00295	CcSEcCtD
Probenecid—Dermatitis—Epirubicin—sarcoma	8.24e-05	0.00293	CcSEcCtD
Probenecid—Headache—Epirubicin—sarcoma	8.2e-05	0.00291	CcSEcCtD
Probenecid—Dizziness—Doxorubicin—sarcoma	8.01e-05	0.00284	CcSEcCtD
Probenecid—Nausea—Epirubicin—sarcoma	7.77e-05	0.00276	CcSEcCtD
Probenecid—Vomiting—Doxorubicin—sarcoma	7.7e-05	0.00273	CcSEcCtD
Probenecid—Dermatitis—Doxorubicin—sarcoma	7.63e-05	0.00271	CcSEcCtD
Probenecid—ABCB1—lymph node—sarcoma	7.6e-05	0.000862	CbGeAlD
Probenecid—Headache—Doxorubicin—sarcoma	7.59e-05	0.00269	CcSEcCtD
Probenecid—Nausea—Doxorubicin—sarcoma	7.19e-05	0.00255	CcSEcCtD
